PATENT CLAIM ANALYSIS

Application Number: 15779177
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "557000"]

Abstract:
This invention relates to preparations comprising a butyrate salt for enteral administration for use in the treatment of conditions and diseases that are not diseases or conditions of the intestine and/or are associated with systemic inflammation. Preparations comprising a butyrate salt for enteral administration were found useful in the treatment of osteoarthritis, arteriosclerosis, rheumatism, psoriasis, multiple sclerosis, Alzheimer's' disease, Parkinson's disease, migraine, autism, depression, impaired kidney functioning, idiopathic subfertility, recurrent abortion, recurrent implantation failure, hangovers, and gout.

Claim (Index 11):
A kit comprising a combination of a gastro-resistant formulation for oral administration according to  claim 1 , and a preparation comprising a butyrate salt in the form of a suppository for insertion in the rectum.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.59016
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14185786', '14860092', '15090377', '12594553', '15255102']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7319208155864863
- 35 USC 102 Novelty (BERT): 0.48263239185166
- Combined Prediction Score: 0.7069919732130037
- Mean Citation Score: 162.422474
- Max Citation Score: 166.10466
- Similarity Product: 113.63277743222235

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test